Many paramyxoviruses appear to require cytoskeletal elements for particular steps in the virus life cycle. Measles virus and Sendai virus exhibit a requirement for microtubules in replication in vitro, whereas parainfluenza virus type 3 and RSV require actin for replication. To further elucidate the role of cytoskeletal function and rearrangement in the viral life cycle of RSV, we investigated the efficiency of virus entry, transcription, replication, and budding in the presence of a variety of pharmacological agents that stabilize or depolymerize actin or microtubules. We found that alteration of microtubule or actin function resulted in blocks at entry, formation of cell-associated virus, virus release, local cell-to-cell spread, and syncytium formation. Actin and microtubules act in cooperation to facilitate replication of RSV, although microtubules play a dominant role in the formation of cell-associated virus while actin plays a more prominent role in virus release. D 2004 Elsevier Inc. All rights reserved.
Introduction
Respiratory syncytial virus (RSV) is a member of the paramyxovirae family and the leading cause of viral lower respiratory disease in infants and young children. The virus contains a single-stranded, negative-sense RNA genome that encodes 11 proteins. A better understanding of the virus life cycle and the interactions of RSV with its host cell environment is needed to facilitate studies of viral pathogenesis, and the development of antiviral or immunotherapeutic interventions.
Viruses use the host cell machinery to facilitate entry, replication, transport, and release of progeny virions. The intricate structural system that is referred to as the cytoskeletal network is composed of actin, microtubules, intermediate filaments, and other elements. Actin and microtubules form the majority of the cytoskeletal framework of the cell and provide the infrastructure for major trafficking pathways of cellular proteins and vesicles. Actin is present in non-muscle cells in a globular monomeric form (G-actin), and in a filamentous form (F-actin) that constitutes the polymerized microfilament. Actin microfilaments are in a dynamic state characterized by rapid cycles of polymerization/depolymerization that occur in response to varying stimuli (Wear et al., 2000) . The other major constituent of the cytoskeleton is the microtubule network, which is made of polymerized aand h-tubulin. Microtubules achieve highly ordered structures that exhibit an intrinsic polarity. These filaments contribute to the stability and shape of cells, and determine the pathways of vesicle and protein trafficking within the cell with the help of motor proteins (Hunter and Wordeman, 2000) . We have previously shown that the actin motor myosin Vb regulates directional budding of RSV in polarized epithelial cells (Brock et al., 2003) . Recent studies of viral interactions with cellular processes suggest that different viruses use different 0042-6822/$ -see front matter D 2004 Elsevier Inc. All rights reserved. doi:10.1016/j.virol.2004.10.010 elements of the cytoskeleton for entry, transport of viral proteins, function of replication machinery inside the cell, and for viral release (Cudmore et al., 1997; Sodeik, 2000) .
Previous investigators showed that some members of the paramyxovirus family interact directly with the cytoskeleton. Measles virus and Sendai virus require microtubules for efficient replication in vitro, while parainfluenza virus type 3 and RSV replication require actin in vitro (Burke et al., 1998; De et al., 1991; Hill et al., 1986) . Experiments using RSV suggest that this pneumovirus requires actin in either filamentous or monomeric form together with the actin cofactor profilin for optimal replication in vitro (Burke et al., 2000) . While these biochemical experiments suggest a role for actin in RSV replication, the significance of such interactions in living cells is unknown. Actin has been found within the virion particle of RSV and other paramyxoviruses after release from cells, which suggests a possible role for actin in the release of virions from the cell (Fernie and Gerin, 1982; Stallcup et al., 1979; Tyrrell and Norrby, 1978) . Actin has also been shown to play a role in the morphology of cell-associated filamentous virus (Roberts and Compans, 1998; Yao and Compans, 2000) . More detailed information is needed about these processes and the role of the cytoskeleton in other life cycle steps of RSV.
We used a panel of chemical inhibitors that interfere with the normal polymerization or depolymerization states of microfilaments or microtubules to study the role of the cytoskeleton in the RSV life cycle. Previous studies investigated the effect of cytochalasin D and nocodazole on virus replication (Burke et al., 1998) . The recent development of additional actin and microtubule inhibitors allows for more defined studies of virus/cytoskeletal interactions (Spector et al., 1999) . We sought to determine whether RSV replication in cells requires proper function of microtubules or actin, and if so, to determine the stage of the virus life cycle during which those requirements were most evident. We found that alteration of either type of major cytoskeletal elements significantly affected each step of the RSV life cycle examined, except for viral genomic replication and transcription. Our experiments also suggest that microtubules play a dominant role during processes that result in the production of cell-associated infectious virus, while actin filaments exert a greater effect on egress of virus from the cell.
Results

Proper function of both microtubules and actin is required for entry and early replication events
In order to determine if proper function of the cytoskeleton is required for entry and early steps of RSV replication, we treated cells with a panel of cytoskeletal inhibitors. We selected inhibitors that function in stabilization or destabilization of either microtubules or actin. We used each inhibitor at a concentration determined by preliminary experiments that mediated highest activity with a minimal amount of cell death (data not shown). The mechanism of action of the inhibitors along with the concentration of each inhibitor that was used in these studies is shown in Table 1 . Inhibitors were added to cells either 3, 6, or 12 h prior to virus adsorption or added only after viral absorption, as indicated in Table 2 . An RSV strain with the GFP gene incorporated within the virus genome was used so that live virus-infected cells could be visualized and counted by GFP expression and the morphology of infectious foci could be followed throughout the virus life cycle (Hallak et al., 2000) . These experiments allowed us to determine the effect of inhibitors on viral entry and early replication, on local cell-to-cell spread, and on syncytium formation caused by cell-to-cell fusion, which are hallmarks of RSV infection in culture. Cells were visualized at 14 h post-infection and fluorescence focus units (ffu) representing successful virus entry and early replication events were counted. The resulting virus titer was expressed as log 10 ffu/ ml (Table 2) . We found that cell cultures that were exposed to the inhibitors before virus entry showed a significant reduction in ffu compared to the control cells that were treated only after viral absorption. Significant reductions of RSV infectious foci were mediated by the cytoskeletal inhibitors latrunculin A, cytocholasin D, and jasplakinolide, which each caused a 5-to 10-fold reduction in viral ffu titer. This inhibition was observed at the earliest time point (3-h pretreatment during cytochalasin D treatment). This finding was in concordance with the rapid change in morphology caused by these cytoskeletal inhibitors. The microtubule inhibitors nocodazole and taxol caused a reduction of virus of 9-fold and 3-fold, respectively by 12 h. The magnitude of the reduction caused by the microtubule inhibitors gradually increased with time. This finding is consistent with the relatively slow kinetics of action of these inhibitors, which do not cause striking changes in cellular morphology until the longer preincubation periods. Microtubules and actin filaments play significant roles in the release and assembly of RSV Inhibitor treatments after virus absorption did not mediate a significant reduction in the number of infectious foci of RSV compared to solvent alone (Table 2 ). This finding allowed us to study the role of the cytoskeleton in the viral life cycle steps after entry and early replication. We determined the effect of each of the inhibitors on the later stages in RSV replication by adsorbing virus at either a low or high M.O.I. followed by the addition of the inhibitors. To differentiate between effects on distinct viral processes such as assembly of cell-associated virus and budding of virions from the cell, we collected the cell fraction and supernatant separately during the course of viral infection for 3 days. After all experiments were completed, the amount of virus present in each fraction was quantitated by virus plaque assay. The results are shown in Fig. 1 . In panels A and C, data for the virus collected in the supernatant following infection at either a high ( Fig. 1A ) or low (Fig. 1C ) M.O.I. is shown. Each inhibitor caused a 10-to 100-fold inhibition of viral titer in the released pool of virus. Some of the inhibitors mediated a rapid inhibition that was apparent by the reduction of virus titer even on the first day post-infection. The amount of reduction increased significantly on day 2 and 3 post-infection, with the latter inhibition being the greatest. This pattern of inhibition was observed for all cytoskeletal inhibitors, and was seen in both the high and low M.O.I. experiments. At a high M.O.I., viral spread is not necessary within the culture to achieve a productive infection of each cell. The inhibition we observed in these experiments was likely due to a block in release of virus because an inhibition was observed in both the high and low M.O.I. conditions. Although each of the agents mediated an inhibition, interesting differences were observed in the amount of viral reductions. The actin inhibitors cytochalasin D and jasplakinolide showed the greatest effect on virus release, each mediating a 1000-fold reduction on day 3 of the high M.O.I. experiments and even higher reductions in the low M.O.I. experiments.
We also examined the amount of virus present in the cellassociated fraction from these samples. As shown in panels B and D of Fig. 1 , the inhibitors mediated only a minor reduction in the titer of cell-associated virus, in contrast to the large effect on released virus. The actin inhibitor latrunculin A had little if any effect on cell-associated viral production in the high M.O.I. reduction experiments (Fig.  1B) . The microtubule inhibitors nocodazole and paclitaxel mediated the greatest reduction in viral growth in the cellassociated fraction. The inhibition caused by these agents in the high M.O.I. studies could be distinguished from the effects of other inhibitors on day 2 (over a 10-fold reduction), but by day 3 the reduction was no longer apparent in the single round of infection studies. The results of the low M.O.I. cell-associated studies (Fig. 1D) show a modest decrease in virus production caused by each of the inhibitors. Since the low M.O.I. experiments represent a situation in which the virus must spread in the culture from cell to cell for optimal yields, the inhibition seen under these conditions reflects a combination of the modest reduction seen in the cell-associated fraction and the large inhibitory effect on the release of virus. These results suggest that microtubule inhibitors reduced both the total amount of virus produced in the cell and the amount of virus that was allowed to egress from cells.
Microtubules mediate a greater effect on viral assembly, whereas actin filaments play a dominant role in the release of virus
The data from the inhibition studies above showed that two of the actin inhibitors mediated the greatest reduction on the released virus, and two of the microtubule inhibitors mediated the greatest effect on the cell-associated virus. To analyze whether these effects could be generalized, we measured the reduction (log 10 pfu/ml) on day 2 for each inhibitor under all four conditions and calculated the ratio of reduction in the released virus versus the reduction in the cell-associated virus. A graphical representation of these ratios is shown in Fig. 2 . In this analysis, a value of 1 represents an equivalent effect of the inhibitor on virus release and cell-associated virus production, a value greater than 1 represents a situation where the inhibitor had a greater effect on the release of virus, and a value less than 1 represents inhibitors that had a greater effect on the formation of cell-associated virus. The ratio of inhibition of all of the actin inhibitors grouped together with values above 1, showing that actin is especially important in the release of virus from the cell. We also noted that all of the microtubule inhibitors group together with values near or below 1, showing that microtubules play an important role in both processes but with a larger effect on the production of cell-associated virus.
Disruption of the cytoskeleton does not affect the ability of RSV to accomplish proper transcription of its genes
In the previous studies, we showed that the cytoskeletal inhibitors caused a block in RSV viral production in the cell-associated fractions. We sought to determine if the virus was blocked at the replication or transcription step of its life cycle, when the cytoskeleton was altered. To fully test this, we examined by real-time quantitative RT-PCR assays the ability of RSV to transcribe two different viral genes, N and F. The cells were infected with RSV at a high or low MOI and then treated with an inhibitor for actin or microtubules or with solvent alone. After 1 day, total RNA was extracted from cell lysates and assayed for level of RSV N or F RNA, and also a cellular housekeeping gene GADPH to control for amount of RNA loaded into the assay. To test for the amount of viral RNA, we used gene-specific probes that had been previously described to be sensitive and specific for the N and F genes of RSV wild-type strain A2 (Hu et al., 2003; Mentel et al., 2003) . The level of transcription of the cellular housekeeping gene GADPH was also used to control for any sample-to-sample variation in the RNA extraction. As proof of the high level of reproducibility of the experiments, the standard deviation within sample batches was at the greatest only F0.604, and signal for RSV RNA was never detected in negative controls (results not shown). The amount of RSV transcription was determined by the cycle number at which the amount of fluorescence reached 10 standard deviations over the background (designated the C T ). To determine the level of RSV RNA, we normalized the results from each sample by subtracting the C T of the GADPH assay from the RSV specific C T value to arrive at the DC T (Table 3) . To determine the effect the cytoskeleton inhibitors had upon RSV RNA levels, the DC T values of the inhibitor-treated samples were subtracted from the DC T values in the presence of solvent alone to yield a DDC T value. To understand the significance of these values more intuitively, we converted the DDC T values to fold difference, as shown in Table 3 . These results showed that there was very little difference between the inhibitor-treated samples and those treated with solvent alone. None of the samples showed a difference of RSV RNA level more than 2-fold, which is the limit of detection of this assay.
Actin polymerization inhibitors differ in effect on local spread of virus and cell-to-cell fusion
Next, we examined the role of the cytoskeleton on the spread of virus, which is essential to a robust infection in culture. RSV causes distinct changes in the morphology of HEp-2 cells during spread in culture, which occurs by the local spread of infectious viral particles to surrounding cells and by the fusion of cell membranes, creating multinucleated giant cells in a formation designated a syncytium. Using the RSV-GFP virus, we visualized the number and morphology of live infected cells during disruption of the functional elements of cytoskeleton. The inhibitors mediated varying degrees of inhibition of local spread and cellto-cell fusion. Of interest was the difference observed between the effect of two actin inhibitors latrunculin A and cytochalasin D on the local spread during productive viral infection (Fig. 3 ). Both of these inhibitors are actin filament destabilizers, but they differ in their mode of action. Latrunculin A binds to G-actin, the monomeric form, and sequesters it from the formation of filaments, whereas cytochalasin D binds to filaments directly and disrupts filament formation (Spector et al., 1999) . Under conditions of a low M.O.I., by day 2 post-infection we observed large foci of virus-infected cells and syncytium formation incorporating large numbers of cells within these foci. These syncytia continued to spread to the whole monolayer, causing massive syncytium formation by day 3. With both the latrunculin A and cytochalasin D treated cells, local spread did not occur by day 2, and only single-cell foci were visible. By day 3, a distinction was seen between the two inhibitors. The cytochalasin D treatment continued to inhibit local spread, as evidenced by the restriction to single cell foci, but the latrunculin A treatment allowed clusters of infected but unfused cells within foci, likely representing the local spread of virus to neighboring cells. Surprisingly, syncytium formation was not observed in either culture condition, even when the latrunculin A treatment allowed infection of cells in close proximity to each other. By day 4, cytocholasin D and latrunculin A exhibited similar effects on local spread, but no substantial syncytium formation was seen. These results suggest that cell-cell fusion resulting in syncytium formation requires actin filament formation, and that local spread of virus does not require syncytium formation.
Discussion
This study shows that the actin and microtubule networks play several important roles in the growth and spread of RSV in cell culture. We used a panel of cytoskeletal inhibitors to determine the extent of the requirement for cytoskeletal elements in viral growth and spread. We found that interruption of the proper formation of actin or microtubule elements altered the efficiency of virus replication at every step within the viral life cycle that was tested, from entry to viral spread, except for viral genome replication and transcription. We observed up to a 10-fold reduction of the efficiency of viral entry and early replication when inhibitors were present prior to viral infection. This inhibition of virus infectivity, as measured by reduction of RSV-GFP fluorescent foci, could either be occurring at the stage of entry of virus into the cell or during the formation or function of the transcriptional machinery. Quantitative RT-PCR studies showed that there was no difference in the amount of production of RSV RNA when the virus was grown in the presence of inhibitors. Therefore, the entry of the virus is most likely the stage of the virus life cycle that was affected at early time points. Little is known about the mechanism of fusion of the RSV envelope with the cellular envelope but it is probable that this process requires the proper function of the cytoskeletal network.
We also sought to determine what effect the inhibitors would have on the later stages of assembly of virus within the cell-associated fraction, and on the release of correctly assembled virus from the cell. We found that both classes of inhibitors had a large inhibitory effect on the release of virus from the cell. The actin inhibitors jasplakinolide and cytochalasin D mediated up to 1000-fold reductions in viral yield into the supernatant. This marked inhibition was observed in studies conducted using either high or low M.O.I. conditions, showing that the large reduction observed was not exaggerated by a cumulative effect during multiple rounds of replication. In experiments designed to determine the inhibitory effect on virus assembly occurring in the cell fraction prior to release, we observed that treatment with the microtubule inhibitors nocodazole and paclitaxel resulted in the most dramatic reduction of viral yield. Interestingly, virus assembly in the presence of latrunculin A was not significantly different than that in the absence of inhibitor, despite major morphological changes in the cells. These studies demonstrate that proper formation and function of both actin and microtubules contributes to virus assembly and release. The relative magnitude of inhibition shows that microtubule filaments play a greater role in the assembly of the virus, as measured by formation of virus in the cell fraction, whereas actin filaments principally facilitate the release of RSV.
Previous investigators have demonstrated a requirement for either microtubules or actin during in vitro transcription and replication of some paramyxoviruses (De et al., 1993; Moyer et al., 1990) . In vitro replication of RSV was shown to require actin but not microtubules (Burke et al., 1998) . It is a possibility that the cytoskeletal network is involved in a direct interaction with the viral replication machinery, as suggested by previous in vitro transcription work, or that microtubules and actin provide an organizing support or scaffolding mechanism for the assembly of virus transcriptional complexes. To address this, we looked at the ability of RSV to efficiently replicate and transcribe the viral genome in the presence of the inhibitors. Our quantitative studies of the level of RSV RNA in infected cells showed no effect of the inhibitors on the level of RNA produced. These results do not necessarily contradict previous in vitro data suggest- ing that actin in the polymerized or nonpolymerized state is necessary for transcription. Our results do suggest, however, that polymerized cytoskeleton is not necessary for organizing a complex for transcription in cells. RSV must accomplish virus spread within the respiratory tract following inoculation in order to establish a productive infection. We suggest that RSV spreads in HEp-2 cell monolayer culture by two principal independent mechanisms (1) local spread of budded virus to uninfected cells within close proximity and (2) spread through the fusion of infected cells to adjacent uninfected cells creating a syncytium. We observed that both actin inhibitors tested completely prevented syncytium formation. We also noted that there was a marked difference between the actin inhibitors in potency for inhibition of local spread. The cytochalasin D treatment completely inhibited local spread to uninfected cells, whereas latrunculin A treated cells showed a rosette of infected neighboring cells late in infection, suggesting local spread in the absence of syncytium formation at day 3. These two inhibitors destabilize actin filaments through different mechanisms. Latrunculin A depletes the G-actin stores used to make or repair actin filaments, while cytochalasin D disrupts the filament directly (Spector et al., 1999) . These findings are particularly interesting because they show that (1) actin filaments are required for syncytium formation, (2) decreasing the availability of Gactin to make actin filaments is less important to the local spread of RSV in culture than the disruption of the filament itself, and (3) the mechanisms underlying local spread of virus and cell-to-cell fusion differ. Interestingly, this phenomenon may be unique to RSV among the paramyxoviruses. Previously, investigators looked at the effect of latrunculin A on a related paramyxovirus, measles virus (Berghall et al., 2004) . Those studies showed that latrunculin A did not inhibit the syncytium formation caused by measles.
In summary, we studied the role of the cytoskeleton in RSV replication and found that the two major components of the cytoskeleton, microtubules and actin, are required for virus entry and early replication, cell-associated processes resulting in virus assembly, release of the virus, and syncytium formation.
Materials and methods
Cells and viruses
HEp-2 cell monolayer cultures were maintained in Opti-MEM I medium (Life Technologies) supplemented with glutamine, gentamicin, amphotericin B, and 2% fetal bovine serum. RSV wild-type strain A2 was previously described (Coates et al., 1966) . A green fluorescent protein (GFP) expressing RSV was described previously and kindly provided by Mark Peeples and Peter Collins (Hallak et al., 2000) . Working suspensions of viruses were prepared by propagating virus in HEp-2 cell monolayer cultures until cultures exhibited significant cytopathic effect. The virusinfected cell culture supernatant and cell fractions were collected, and cellular debris was removed by centrifugation for 20 min at 2000 Â g. Virus-containing supernatant was collected, frozen in 1-ml aliquots, and stored at À80 8C until use.
Inhibitors
Cytochalasin D (Sigma catalog # C-8273) was reconstituted in ethanol to a concentration of 2 mg/ml and stored at À20 8C. Jasplakinolide (Molecular Probes, catalog # J-7473) was reconstituted in methanol to a concentration of 1 mg/ml and stored at À20 8C. Latrunculin A (Biomol, catalog # T-119) was reconstituted with ethanol to a concentration of 1 mg/ml. The microtubule inhibitor nocodazole (Sigma, catalog #M-1404) was reconstituted with DMSO to a concentration of 10 mg/ml. Lastly, paclitaxel (Sigma, catalog #T-7402) was reconstituted in ethanol to a concentration of 25 mg/ml. All inhibitors were tested in preliminary experiments to determine an appropriate working concentration to use in experiments. We sought to identify the amount of inhibitor that caused a majority of cells to be affected by the inhibitor, as measured by a distinctive change in cellular morphology, with the least amount of toxicity. Toxicity was measured by treating HEp-2 cell monolayer cultures with varying concentrations of inhibitor for 3 days. Each day, the cells that had been released into the supernatant and trypsin-released adherent cells were collected. Cell samples were then collected by centrifugation at 1400 Â g and resuspended in equal volumes. Samples were stained with trypan blue, and live/ dead cells counts were preformed separately with a hemocytometer. The optimal concentrations of inhibitors that were determined and used in the experiments are listed in Table 1 .
Studies of the effect of inhibitors on entry and early replication events
HEp-2 cell monolayer cultures were grown to 90% confluence on 96-well tissue culture plates. Monolayers were incubated for 3, 6, or 12 h in medium containing either the desired concentrations of inhibitors or solvent only. After incubation, the inhibitor medium was removed and replicate cell monolayer cultures were infected with RSV-GFP using 10-fold dilutions of virus in medium or with inhibitors, and virus was allowed to adsorb for 1 h at 37 8C. All wells were washed with medium, and fresh medium containing either inhibitor or solvent alone was added. All infected cultures were incubated at 37 8C in 5% CO 2 . After 14 h, infected cells were visualized with a Nikon TE300 microscope using epifluorescence. The virus titer under these conditions was determined using a fluorescent focus assay, and these values were expressed as the number of infected cells per milliliter as previously described (Shaw et al., 1985) . Briefly, the number of infected cells/ml was calculated by counting all of the fluorescent foci in one sweep across each well of the 96-well plate using a 10Â objective. This number of foci was multiplied by 2.8, which accounts for the remainder of the well that was not counted and then multiplied by the dilution of virus that was inoculated. This infectious focus number was then expressed as fluorescent focus units/ml (ffu/ml). The average value of duplicate samples is shown in Table 2 . Photomicrographs of representative fluorescent foci showing infected cell morphology or syncytium formation were obtained at the same positions at 1, 2, or 3 days postinfection. Representative photomicrographs were then used to count the number of cells per fluorescent focus, as indicated in Fig. 3 .
Studies to determine the inhibitor effect on RSV yield when inhibitor was added after viral entry
HEp-2 cell monolayer cultures at 90% confluence were inoculated with RSV strain A2 at a multiplicity of infection (M.O.I.) of 0.3 or 8 for 1 h at 37 8C. Cells were washed and medium with inhibitors or solvent was added. Supernatant and cell fractions were collected separately at 1, 2, or 3 days post-infection. The supernatant was frozen immediately in cryovials, while the cell-associated fractions were subjected to three freeze/thaw cycles to disrupt cells and release virus, and then stored at À80 8C until analysis. After all samples were collected, the viral titer of each sample was determined in duplicate by virus plaque assay in HEp-2 cell monolayer cultures as described (Crowe et al., 1994) . End-point titers were calculated as log 10 pfu/ml and the mean and standard deviation of the reduction mediated by each inhibitor was calculated.
Quantitative assay for RSV RNA HEp-2 cell monolayer cultures at 90% confluence were inoculated with RSV strain A2 at a M.O.I. of 0.3 or 8, or were mock infected, for 1 h at 37 8C. Cells were washed and medium with inhibitors or solvent was added. Supernatant and cell fractions were collected 24 h post-infection. Cells and cell debris were pelleted, and media removed and discarded. The cell pellet was washed with PBS and then cells were lysed with RNeasy RLT buffer according to the manufacturer's instructions, and frozen at À80 8C. Total RNA was extracted using the RNeasy kit (Qiagen) according to the manufacturer's instructions along with the additional step of DNAse digestion to rid the sample of DNA prior to the RT-PCR. In a two-step RT-PCR assay, 50 Al RNA was transcribed using the High Capacity cDNA Archive kit (ABI) according to the manufacturer's instructions. In brief, the RT conditions were 10 min at 25 8C, 2 h at 37 8C, and then a 4 8C hold. The resulting cDNA product was then stored at 4 8C briefly until the real-time PCR assay was performed. The cDNA was used in three separate identical reactions to determine the level of RSV cDNA for the RSV N or F genes, or for the cellular housekeeping gene GAPDH as a RNA control. Both the N and F gene PCR primers were synthesized by Invitrogen and reconstituted to a 200 AM concentration, and N and F gene specific Taqman probes were synthesized by Applied Biosystems and were labeled with 6-FAM. The GAPDH primers and probes were supplied by Applied Biosystems (Assays-On-Demand) and were also 6-FAM labeled and were used as directed by the manufacturer. The sequences of the primers and probes for the N protein were previously described (Hu et al., 2003) and were used at 0.5 AM for each primer and 0.2 AM concentration for the N probe. F protein primers and probe sequences were previously described (Mentel et al., 2003) , and were used at concentrations of 0.3 AM of primers, and 0.1 AM of the probe. Amplification was carried out using Omnimix HS beads (Takara, Fischer Scientific), one bead for 2 Â 25 Al reactions. Each bead was reconstituted in a 50 Al volume including 15 Al of cDNA, and the primers and probes. Each of the triplicate infected cell lysate samples was assayed in duplicate quantitative RT-PCR assays for RNA level of the RSV N, F, or cellular GADPH genes. The reaction was carried out using the Smart Cycler II (Cepheid) with 1 cycle for 2 min at 50 8C and 10 min at 95 8C, followed by up to 30 cycles of 15 s at 95 8C, or stopping automatically five cycles after the fluorescence reached the cycle threshold (C T ). During amplification, the detector monitored fluorescence emissions at every thermal cycle. The C T was determined automatically by the cycler when the signal achieved a level that was 10 standard deviations above the background level of fluorescence. Standard precautions were taken throughout the RT-PCR process to avoid cross-contamination. Negative controls and a solvent control were included for each of the inhibitor concentrations. The C T values for the cellular control gene GADPH were subtracted from the RNA C T values to arrive at the cycle number difference in transcription designated the DC T . The average of DC T values was determined for the triplicate samples, and these numbers for each inhibitor at each M.O.I. were compared to the DC T values for solvent alone. The difference of change between virus RNA levels with the inhibitors and without was calculated by subtracting the DC T of the sample treated with solvent alone from the DC T value in the presence of each of the inhibitors, which yielded a DDC T value. For ease of interpretation, these values were converted into fold differences by using the equation of 2 ÀDDC T (Table 3) .
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